MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

A.I. Advisor
published Earnings

ACIU is expected to report earnings to rise 16.06% to -18 cents per share on March 12

AC Immune SA ACIU Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.03
The last earnings report on November 04 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 64.50K shares outstanding, the current market capitalization sits at 329.97M.
View a ticker or compare two or three
ACIU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACIU showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com